zonisamide has been researched along with Drug Refractory Epilepsy in 8 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a summary of clinical cases of oral zonisamide (ZNS) used to treat refractory and super-refractory episodes of status epilepticus (SE)." | 9.05 | Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature. ( Bauer, S; Hubert, K; Knake, S; Rosenow, F; Strzelczyk, A; Voss, M, 2020) |
| "Zonisamide (ZNS) is a new generation antiepileptic drug (AED) used in refractory epilepsy." | 8.12 | Effectiveness of zonisamide in childhood refractory epilepsy. ( Aslan, M; Gungor, S, 2022) |
| "Pregnancy is a state where drug pharmacokinetic changes are more pronounced and more rapid than any other period of life." | 5.48 | Effect of zonisamide on refractory epilepsy during pregnancy in lamotrigine resistant kindled rats. ( Keramati, K; Mahdavi, A; Moezifar, M; Narenji Sani, R; Saberi, N, 2018) |
| "We present a summary of clinical cases of oral zonisamide (ZNS) used to treat refractory and super-refractory episodes of status epilepticus (SE)." | 5.05 | Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature. ( Bauer, S; Hubert, K; Knake, S; Rosenow, F; Strzelczyk, A; Voss, M, 2020) |
| "Zonisamide (ZNS) is a new generation antiepileptic drug (AED) used in refractory epilepsy." | 4.12 | Effectiveness of zonisamide in childhood refractory epilepsy. ( Aslan, M; Gungor, S, 2022) |
| " Two trials provided evidence of a dose-response relationship for this outcome." | 2.66 | Zonisamide add-on therapy for focal epilepsy. ( Behzadifar, M; Bragazzi, NL; Brigo, F; Igwe, SC; Lattanzi, S, 2020) |
| " Two trials provided evidence of a dose-response relationship for this outcome." | 2.58 | Zonisamide add-on therapy for focal epilepsy. ( Behzadifar, M; Bragazzi, NL; Brigo, F; Igwe, SC; Lattanzi, S, 2018) |
| "Pregnancy is a state where drug pharmacokinetic changes are more pronounced and more rapid than any other period of life." | 1.48 | Effect of zonisamide on refractory epilepsy during pregnancy in lamotrigine resistant kindled rats. ( Keramati, K; Mahdavi, A; Moezifar, M; Narenji Sani, R; Saberi, N, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan, M | 1 |
| Gungor, S | 1 |
| Hubert, K | 1 |
| Knake, S | 1 |
| Bauer, S | 1 |
| Voss, M | 1 |
| Rosenow, F | 1 |
| Strzelczyk, A | 1 |
| Brigo, F | 3 |
| Lattanzi, S | 2 |
| Igwe, SC | 2 |
| Behzadifar, M | 2 |
| Bragazzi, NL | 2 |
| Quon, RJ | 1 |
| Meisenhelter, S | 1 |
| Adamovich-Zeitlin, RH | 1 |
| Song, Y | 1 |
| Steimel, SA | 1 |
| Camp, EJ | 1 |
| Testorf, ME | 1 |
| MacKenzie, TA | 1 |
| Gross, RE | 1 |
| Lega, BC | 1 |
| Sperling, MR | 1 |
| Kahana, MJ | 1 |
| Jobst, BC | 1 |
| Tezzon, F | 1 |
| Nardone, R | 1 |
| Narenji Sani, R | 1 |
| Keramati, K | 1 |
| Saberi, N | 1 |
| Moezifar, M | 1 |
| Mahdavi, A | 1 |
| Ortiz-Madinaveitia, S | 1 |
| Serrano-Madrid, ML | 1 |
| Conejo-Moreno, D | 1 |
| Sagarra-Mur, D | 1 |
| Jimenez-Corral, C | 1 |
| Gutierrez-Alvarez, AM | 1 |
3 reviews available for zonisamide and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Ataxia; Cohort Studies; Drug Resistant Epilepsy; Fe | 2020 |
Zonisamide add-on therapy for focal epilepsy.
Topics: Anticonvulsants; Drug Resistant Epilepsy; Drug Therapy, Combination; Epilepsies, Partial; Humans; In | 2020 |
Zonisamide add-on therapy for focal epilepsy.
Topics: Anticonvulsants; Drug Resistant Epilepsy; Drug Therapy, Combination; Epilepsies, Partial; Humans; In | 2018 |
5 other studies available for zonisamide and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Effectiveness of zonisamide in childhood refractory epilepsy.
Topics: Child; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Humans; Reproducibility of Results; R | 2022 |
Factors correlated with intracranial interictal epileptiform discharges in refractory epilepsy.
Topics: Adult; Anticonvulsants; Attention; Carbamazepine; Drug Resistant Epilepsy; Electrocorticography; Fem | 2021 |
Forced normalization and antiepileptic drugs interacting with glutamatergic neurotransmission: Caution is needed.
Topics: Adult; Anticonvulsants; Drug Resistant Epilepsy; Electroencephalography; Female; Glutamic Acid; Huma | 2017 |
Effect of zonisamide on refractory epilepsy during pregnancy in lamotrigine resistant kindled rats.
Topics: Animals; Animals, Newborn; Anticonvulsants; Brain; Drug Resistance; Drug Resistant Epilepsy; Female; | 2018 |
[Early onset epileptic encephalopathy in a patient with mutation in
Topics: Age of Onset; Amino Acid Substitution; Anticonvulsants; Child, Preschool; Drug Resistant Epilepsy; D | 2017 |